Abstract
MA10.04 Evaluation of a Risk-Sharing Agreement for Atezolizumab Treatment in NSCLC Patients: A Strategy to Improve Access in Low Income Countries
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have